Abivax SA (France) Analysis

Abivax Stock Analysis Notes

About 30.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.37. Abivax SA had not issued any dividends in recent years. ABIVAX Socit Anonyme, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America. The company was incorporated in 2013 and is headquartered in Paris, France. ABIVAX is traded on Paris Stock Exchange in France. For more info on Abivax SA please contact the company at 33 1 53 83 08 41 or go to https://www.abivax.com.

Abivax SA Investment Alerts

Abivax Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 277.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abivax SA's market, we take the total number of its shares issued and multiply it by Abivax SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 27th of November, Abivax SA shows the Mean Deviation of 1.99, risk adjusted performance of (0.09), and Standard Deviation of 2.68. Abivax SA technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Abivax SA Price Movement Analysis

Abivax SA Outstanding Bonds

Abivax SA Predictive Daily Indicators

Abivax SA Forecast Models

Abivax SA's time-series forecasting models are one of many Abivax SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abivax SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Abivax SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abivax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Abivax SA. By using and applying Abivax Stock analysis, traders can create a robust methodology for identifying Abivax entry and exit points for their positions.

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.